Propylthiouracil is an anti-thyroid drug used to manage Graves disease and hyperthyroidism. This activity will highlight the mechanism of action, adverse event profile, and other key factors (e.g., dosing, pharmacodynamics, pharmacokinetics, monitoring, relevant interactions) of propylthiouracil pertinent for healthcare team members in the treatment of patients with hyperthyroidism and related conditions.

**Objectives:**
- Identify the mechanism of action of propylthiouracil.
- Describe the potential adverse effects of propylthiouracil.
- Review the monitoring necessary for patients receiving propylthiouracil.
- Summarize interprofessional team strategies for improving care coordination and communication to advance propylthiouracil and improve outcomes.